Nasdaq

Bio-Thera Solutions And Hikma Pharma Say FDA Approved STARJEMZA Injection

(RTTNews) - Bio-Thera Solutions Ltd and Hikma Pharmaceuticals PLC announced that the U.S. Food and Drug Administration has approved STARJEMZA (ustekinumab-hmny) Injection, a biosimilar referencing ...
Nasdaq

Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection

GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets ...
Business Insider

FDA Accepts BioMarin's Supplemental New Drug Application to Expand Use of VOXZOGO® (vosoritide) for Injection to Treat Children with Achondroplasia Under the Age of 5

The Supplemental New Drug Application is Based on Positive Results from Global Randomized Phase 2 Study in Infants and Young Children FDA set PDUFA Target Action Date of October 21, 2023 SAN RAFAEL, ...
WRIC

Surf Bio to Highlight Potential of SnapShot™ Platform to Rapidly Deliver Ultra-High Concentration mAb and Biologic Therapies Via Subcutaneous Injection During PODD 2024

In-vitro and in-vivo data indicate SnapShot enables drug developers to produce high concentration, high dose, subcutaneous formulations of mAbs and biologics Surf Bio CEO, Bryan Mazlish, to deliver ...
BioTechniques

Peek Behind the Paper: Comparing injection methods for high-throughput RNA silencing using CRISPR-rfxCas13d

In this Peek Behind the Paper, we learn more about a recently published paper by Joaquin Abugattas-Nuñez Del Prado (Leiden University, The Netherlands; Universidad Peruana Cayetano Heredia, Lima, Perú ...
Reuters

Baudax Bio Inc Announces Commercial Launch Of Anjeso Injection

* BAUDAX BIO - RECEIPT OF UNIQUE C-CODE AND PASS-THROUGH PAYMENT STATUS EFFECTIVE JULY 1 Source text for Eikon: Further company coverage: ...
Business Wire

Xenco Medical Announces Nationwide Launch of its CancelleX Bio-inspired Spinal Implants, the First Injection-Molded Titanium Foam Implants for Spine Surgery Pre-Attached to ...

SAN DIEGO--(BUSINESS WIRE)--Surgical implant maker Xenco Medical has announced the nationwide launch of the first injection-molded titanium foam spinal implants pre-attached to disposable, composite ...
Seeking Alpha

Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection

This news release contains certain forward-looking statements relating to STARJEMZA ® /BAT2206 or the product pipelines in general of Bio-Thera Solutions and Hikma. Readers are strongly cautioned that ...